- Home
- ORI vs DVA Comparison
ORI vs DVA Comparison
Compare ORI & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORI
- DVA
- Stock Information
- Founded
- ORI 1923
- DVA 1994
- Country
- ORI United States
- DVA United States
- Employees
- ORI N/A
- DVA N/A
- Industry
- ORI Property-Casualty Insurers
- DVA Misc Health and Biotechnology Services
- Sector
- ORI Finance
- DVA Health Care
- Exchange
- ORI Nasdaq
- DVA Nasdaq
- Market Cap
- ORI 10.8B
- DVA 9.4B
- IPO Year
- ORI N/A
- DVA 1995
- Fundamental
- Price
- ORI $46.56
- DVA $120.45
- Analyst Decision
- ORI Strong Buy
- DVA Hold
- Analyst Count
- ORI 2
- DVA 4
- Target Price
- ORI $46.50
- DVA $145.00
- AVG Volume (30 Days)
- ORI 2.0M
- DVA 1.2M
- Earning Date
- ORI 10-23-2025
- DVA 10-29-2025
- Dividend Yield
- ORI 2.50%
- DVA N/A
- EPS Growth
- ORI N/A
- DVA 5.63
- EPS
- ORI 3.32
- DVA 9.76
- Revenue
- ORI $8,748,900,000.00
- DVA $13,317,965,000.00
- Revenue This Year
- ORI $10.22
- DVA $6.24
- Revenue Next Year
- ORI $6.10
- DVA $3.32
- P/E Ratio
- ORI $13.99
- DVA $12.30
- Revenue Growth
- ORI 7.08
- DVA 5.14
- 52 Week Low
- ORI $33.00
- DVA $113.97
- 52 Week High
- ORI $46.63
- DVA $179.60
- Technical
- Relative Strength Index (RSI)
- ORI 72.90
- DVA 46.93
- Support Level
- ORI $40.61
- DVA $113.97
- Resistance Level
- ORI $46.35
- DVA $122.26
- Average True Range (ATR)
- ORI 0.87
- DVA 3.12
- MACD
- ORI 0.42
- DVA 0.38
- Stochastic Oscillator
- ORI 98.51
- DVA 56.23
About ORI Old Republic International Corporation
Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.